Hamilton Capital LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 572 shares of the healthcare conglomerate’s stock after acquiring an additional 29 shares during the period. Hamilton Capital LLC’s holdings in UnitedHealth Group were worth $323,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the company. Sequoia Financial Advisors LLC increased its stake in shares of UnitedHealth Group by 7.2% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 21,970 shares of the healthcare conglomerate’s stock valued at $11,188,000 after acquiring an additional 1,472 shares in the last quarter. Roman Butler Fullerton & Co. raised its stake in UnitedHealth Group by 18.4% during the 2nd quarter. Roman Butler Fullerton & Co. now owns 1,156 shares of the healthcare conglomerate’s stock worth $579,000 after buying an additional 180 shares during the period. M&G Plc raised its position in shares of UnitedHealth Group by 1.4% during the second quarter. M&G Plc now owns 490,926 shares of the healthcare conglomerate’s stock worth $249,881,000 after purchasing an additional 6,657 shares during the period. Bbjs Financial Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $31,000. Finally, Agate Pass Investment Management LLC grew its holdings in UnitedHealth Group by 190.9% during the second quarter. Agate Pass Investment Management LLC now owns 1,446 shares of the healthcare conglomerate’s stock worth $736,000 after buying an additional 949 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms have commented on UNH. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Truist Financial reissued a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, TD Cowen raised their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $626.84.
UnitedHealth Group Stock Performance
NYSE UNH opened at $549.62 on Monday. The company has a fifty day moving average of $586.84 and a 200-day moving average of $559.07. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market capitalization of $505.80 billion, a P/E ratio of 35.81, a P/E/G ratio of 1.61 and a beta of 0.58.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.56 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.63 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- Profitably Trade Stocks at 52-Week Highs
- 2 Nuclear Stocks Powering Big Tech’s Data Center Revolution
- Overbought Stocks Explained: Should You Trade Them?
- How Amazon’s Drone Deliveries Could Boost Profits and Valuation
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- AT&T’s Big Bet on Fiber, 5G, and $10 Billion Buyback Program
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.